Preoperative Herceptin/Navelbine Versus Taxotere/Carboplatin/Herceptin in HER-2 Positive Breast Cancer

NCT00148668 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

81

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Herceptin
DRUG: Navelbine
DRUG: Taxotere
DRUG: Carboplatin

Sponsor

Eric Winer, MD

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]